April 27 (Reuters) - LUMIBIRD SA LBIRD.PA :
* COVID-19 EPIDEMIC HAS ALSO IMPACTED REVENUES, BUT TO A
LIMITED
EXTENT, AS MAJORITY OF PRODUCT LINES ARE CONTINUING TO OPERATE
* Q1 REVENUE EUR 21.9 MILLION VERSUS EUR 24.2 MILLION YEAR
AGO
* END-MARCH FINANCIAL DEBT REPRESENTS EUR 36.6M
* GROUP IS NOT CURRENTLY IN A POSITION TO FORECAST HOW
HEALTH
CRISIS WILL IMPACT REVENUES FOR YEAR
* ORDER BOOK IS STILL ROBUST AND MAJORITY OF PRODUCTS ARE
CONTINUING TO BE SOLD
* END-MARCH CASH, NET OF CURRENT BANK BORROWINGS, TOTALS EUR
48M,
AND FINANCIAL DEBT REPRESENTS EUR 36.6M
* GROUP’S BUSINESS IS RUNNING MORE SLOWLY AS PRODUCTION
CAPACITY
IS BEING AFFECTED BY REDUCED STAFFING LEVELS FOR PRODUCTION THAN
UNDER NORMAL CONDITIONS
* ON CORONAVIRUS: NEARLY 70% OF STAFF ARE OPERATIONAL
* WILL CONTINUE TO FOCUS ON COMBINING ORGANIC AND EXTERNAL
GROWTH
IN THE THREE BUOYANT MARKETS (LIDAR, DEFENSE/SPACE AND MEDICAL)
Source text for Eikon: ID:nBw4BTKfqa
Further company coverage: LBIRD.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))